Free tool
Oncology stocks
We cover 22 companies grouped under the Oncology theme. The median market value in the group is $1.31B. Across the group, the median move over the past trading day is +1.87%. 95% of the 22 with a 200-day average trade above it. Price change over the past year runs from −23.7% to +295.6% across the middle 80 percent of the group, with a median of +58.7%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
22 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| 6MK.DE | Merck & Co., Inc. | $380.73B | Mega cap | +83.96% | Oct 29, 2026 |
| MRK | Merck & Co., Inc. | $371.70B | Mega cap | +88.17% | Oct 29, 2026 |
| ONC | BeOne Medicines AG | $42.58B | Large cap | +21.95% | Nov 5, 2026 |
| BNTX | BioNTech SE | $28.65B | Large cap | +8.55% | Nov 3, 2026 |
| GMAB | Genmab A/S | $21.42B | Large cap | +41.34% | Nov 5, 2026 |
| 0J9P.L | Incyte Corporation | $21.10B | Large cap | +53.55% | Oct 27, 2026 |
| ZLAB | Zai Lab Limited | $2.94B | Mid cap | −23.10% | Nov 5, 2026 |
| XNCR | Xencor, Inc. Common Stock | $2.18B | Mid cap | +265.79% | Nov 4, 2026 |
| ZYME | Zymeworks Inc. | $1.96B | Small cap | +88.54% | Nov 5, 2026 |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +390.10% | Nov 13, 2026 |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +200.39% | Nov 5, 2026 |
| JANX | Janux Therapeutics, Inc. | $1.14B | Small cap | −18.82% | Nov 5, 2026 |
| KURA | Kura Oncology, Inc. | $1.10B | Small cap | +77.65% | Nov 3, 2026 |
| 4587.T | PeptiDream Inc. | $902.75M | Small cap | −28.26% | Nov 11, 2026 |
| NVCT | Nuvectis Pharma, Inc. | $777.72M | Small cap | +298.92% | Nov 3, 2026 |
| PRLD | Prelude Therapeutics Incorporated | $524.86M | Small cap | +418.90% | Nov 11, 2026 |
| 0LOV.L | Verastem, Inc. | $470.33M | Small cap | −21.47% | Nov 3, 2026 |
| 0XOD.L | UroGen Pharma Ltd. | $347.24M | Small cap | +136.32% | Nov 5, 2026 |
| HBP.TO | Helix BioPharma Corp. | $109.87M | Small cap | +35.37% | Oct 29, 2026 |
| HOWL | Werewolf Therapeutics, Inc. | $42.93M | Micro cap | −35.04% | Oct 30, 2026 |
| KYNB | Kyntra Bio, Inc. | $32.80M | Micro cap | −23.80% | Nov 9, 2026 |
| BFRI | Biofrontera Inc. | $22.43M | Micro cap | +63.77% | Nov 11, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.